Wed, June 5, 2024
[ Wed, Jun 05th 2024
] - WOPRAI
Tue, April 30, 2024
[ Tue, Apr 30th 2024
] - WOPRAI
Wed, April 17, 2024
[ Wed, Apr 17th 2024
] - WOPRAI
Thu, April 4, 2024
[ Thu, Apr 04th 2024
] - WOPRAI
Mon, December 18, 2023
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
Fri, October 27, 2023
[ Fri, Oct 27th 2023
] - WOPRAI
Fri, July 14, 2023
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
[ Fri, Jul 14th 2023
] - WOPRAI
Rajesh Kumar Upgraded (ABBV) to Strong Buy and Held Target at $185 on, Jun 5th, 2024
Rajesh Kumar of HSBC, Upgraded "AbbVie Inc." (ABBV) to Strong Buy and Held Target at $185 on, Jun 5th, 2024.
Rajesh has made no other calls on ABBV in the last 4 months.
There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 0 agree with Rajesh's Rating of Hold.
These are the ratings of the 7 analyists that currently disagree with Rajesh
- Louise Chen of "Cantor Fitzgerald" Initiated at Buy and Held Target at $200 on, Friday, May 17th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
- Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Monday, April 29th, 2024
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, February 6th, 2024
- Gary Nachman of "Raymond James" Maintained at Buy with Increased Target to $189 on, Tuesday, February 6th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $200 on, Monday, February 5th, 2024
Contributing Sources